LENSAR, Inc.
NASDAQ:LNSRMedical - Devices
-$0.51 today
- Market cap
- $59.63M
- Beta
- 0.87
- P/E (TTM)
- 2.4
- EPS (TTM)
- $2.42
Volume 0.06M
Average 0.09M
LNSR EPS (Diluted)
Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.
LENSAR, Inc.NASDAQ: LNSR
EPS (Diluted) · Q1 FY2026 · quarter ended Mar 2026
EPS (Diluted) turns positive
Q1 FY2026 EPS (Diluted) was $0, compared with -$2.32 a year earlier. Trailing-twelve-month EPS (Diluted) was -$0.58.
Context
- EPS (Diluted) grew in size in 2 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether EPS (Diluted) reaches the consensus estimate from 1 analysts of -$0.12 (+96.0%) for the fiscal year ending Dec 2026, a step up from the -5.1% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $0+101.9% QoQ
- Last fiscal yearDec 2025
- -$2.87-5.1% YoY
- LTMMar 2026
- -$0.58+88.1% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +100.1% | -10.0% | -110.1 pp |
| 1 year | -5.1% | +96.0% | +101.1 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Diluted) history
USD · from the income statement
- Latest · FY2025
- (2.87) USD
- Year-over-year change
- -5.1%
| Period | Period end | EPS (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (2.87) | -5.1% |
| FY2024 | 2024-12-31 | (2.73) | -108.4% |
| FY2023 | 2023-12-31 | (1.31) | +33.2% |
| FY2022 | 2022-12-31 | (1.96) | +6.7% |
| FY2021 | 2021-12-31 | (2.10) | — |
EPS (Diluted) vs competitors
How LNSR compares with its peers on the latest reported figures
- LNSR's LTM Mar 2026 EPS (Diluted) of -$0.58 is the 2nd highest of the 10 companies compared; the peer median is -$1.25.
- Its year-over-year change of +88.1% is the highest of 10, against a peer median of -1.6%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | -$0.37 | +6.3% | — | |
| LTM Mar 2026 | -$0.58 | +88.1% | — | |
| LTM Mar 2026 | -$0.67 | +35.6% | — | |
| LTM Mar 2026 | -$0.79 | +79.6% | — | |
| LTM Mar 2026 | -$1.11 | -7.8% | — | |
| LTM Mar 2026 | -$1.25 | -1.6% | — | |
| LTM Mar 2026 | -$1.41 | -24.8% | — | |
| LTM Mar 2026 | -$3.38 | -134.7% | — | |
AVRAnteris Technologies Global Corp. | LTM Mar 2026 | -$4 | -38.9% | — |
| LTM Mar 2026 | -$6.6 | +3.9% | — | |
| Peer median (excluding LNSR) | -$1.25 | -1.6% | — | |
Competitors are the stored peer set for LNSR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 34.46M | 35.36M | 42.16M | 53.49M | 58.44M |
| Cost of Revenue | 16.63M | 15.4M | 21.06M | 27.64M | 31.31M |
| Gross Profit | 17.83M | 19.96M | 21.11M | 25.85M | 27.12M |
| Gross Margin | 51.8% | 56.4% | 50.1% | 48.3% | 46.4% |
| Research & Development | 12.36M | 11.81M | 6.14M | 5.33M | 5.62M |
| Selling, General & Admin | 23.89M | 27.17M | 26.1M | 26.49M | 45.16M |
| Operating Expenses | 37.49M | 40.13M | 33.34M | 36.52M | 51.7M |
| Depreciation & Amortization | 2.76M | 3.41M | 3.52M | 3.93M | 4.5M |
| EBITDA | (16.84M) | (16.51M) | (10.87M) | (3.01M) | (29.78M) |
| EBITDA Margin | -48.9% | -46.7% | -25.8% | -5.6% | -51.0% |
| Operating Income | (19.65M) | (20.18M) | (12.23M) | (10.67M) | (24.58M) |
| Operating Margin | -57.0% | -57.1% | -29.0% | -19.9% | -42.1% |
| Interest Income | 34K | 17K | 85K | 103K | 91K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 51K | 263K | (2.15M) | (20.74M) | (9.7M) |
| Income Before Tax | (19.6M) | (19.91M) | (14.38M) | (31.4M) | (34.28M) |
| Pre-Tax Margin | -56.9% | -56.3% | -34.1% | -58.7% | -58.7% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (19.6M) | (19.91M) | (14.38M) | (31.4M) | (34.28M) |
| Net Margin | -56.9% | -56.3% | -34.1% | -58.7% | -58.7% |
| EPS (Basic) | (2.10) | (1.96) | (1.31) | (2.73) | (2.87) |
| EPS (Diluted) | (2.10) | (1.96) | (1.31) | (2.73) | (2.87) |
| Weighted Avg Shares | 9.37M | 10.16M | 10.97M | 11.52M | 11.96M |
| Weighted Avg Shares (Diluted) | 9.37M | 10.16M | 10.97M | 11.52M | 11.96M |
LENSAR, Inc.
NASDAQ:LNSR
Intrinsic Alpha fair value
Locked
Current Price
$4.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.